Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
JP:4552
Stock Latest News
Company Announcements
JCR Pharmaceuticals Deepens Fucosidosis Research With New Long-Term Patient Study
2d ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Posts Wider Quarterly Loss but Keeps Earnings and Dividend Outlook Intact
8d ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Releases FY2026 Q1 Briefing Materials With Key Investor Disclaimers
8d ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Completes Restricted Stock Compensation Transaction
16d ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Sets 2026–2027 Timeline to Launch Givinostat for Duchenne Muscular Dystrophy in Japan
24d ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Corrects FY2025 Results as Profit Rebounds and Dividend Held Steady
2M ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Corrects FY2024 Results as Weak Performance Prompts Closer Scrutiny
2M ago
4552
Premium
Company Announcements
JCR Pharmaceuticals to Grant Restricted Treasury Shares as Long-Term Incentive
2M ago
4552
Premium
Company Announcements
JCR Deepens Strategic Alliance With Major Shareholder MEDIPAL While Maintaining Independence
2M ago
4552
Premium
Company Announcements
JR-446 Trial Signals Early Rare-Disease Catalyst for Medipal and JCR
2M ago
Premium
Company Announcements
JCR Pharmaceuticals Corrects Q1 FY2025 Results While Maintaining Full-Year Profit Outlook
3M ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Issues Partial Corrections to FY2024 Consolidated Results Amid Challenging Year
3M ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Corrects Interim Results but Confirms FY2025 Outlook and Dividend Plan
3M ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Revises Past Financial Results After Accounting Error Review
3M ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Corrects Nine-Month FY2025 Earnings Disclosure
3M ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Issues Cautious FY2025 Results Briefing Notice
3M ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Returns to Profit but Warns of Earnings Drop Amid Sales Growth
3M ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Raises Earnings Outlook on Firm Sales and FX Gains
3M ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Overhauls Leadership and Structure to Drive Global Biopharma Growth
5M ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Swings Back to Profit and Lifts Full-Year Outlook
6M ago
4552
Premium
Company Announcements
JCR Books ¥1.88 Billion Government Subsidy as Extraordinary Income for Q3 FY2025
6M ago
4552
Premium
Company Announcements
JCR Pharmaceuticals Issues FY2025 Q3 Results Briefing With Caution on Outlook
6M ago
4552
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
